Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated <i>In Vitro</i> and with Clinical SpecimensJasper Fuk‐Woo Chan, Kwok‐Yung Yuen, Cyril Chik‐Yan Yip et al.|Journal of Clinical Microbiology|2020Cited by 936
SARS-CoV-2 infects human neural progenitor cells and brain organoidsBao‐Zhong Zhang, Jian‐Dong Huang, Hin Chu et al.|Cell Research|2020Cited by 336
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivoShuofeng Yuan, Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan et al.|Antiviral Research|2017Cited by 134
Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical SpecimensCyril Chik‐Yan Yip, Kwok‐Yung Yuen, Chi-Chun Ho et al.|International Journal of Molecular Sciences|2020Cited by 98
The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategyJasper Fuk‐Woo Chan, Kwok-Yung Yuen, Gang Lu et al.|Antiviral Research|2018Cited by 46